Table 1 The information of relevant epidemiological articles
Number | Title | First author | Year | Location | Total sample | Experimental group | Control group | Nos |
|---|---|---|---|---|---|---|---|---|
1 | An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervix | Thomas DB | 1973 | USA | 626 | 49/324 (15.1%) | 18/302 (6.0%) | 8 |
2 | The association of sexually transmitted diseases with cervical intraepithelial neoplasia: a case–control study | Guijon FB | 1985 | Canada | 84 | 1/32 (3%) | 1/52 (2%) | 6 |
3 | Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia | Guijon F | 1992 | Canada | 185 | 4/106 (3.8%) | 4/79 (5.1%) | 8 |
4 | The association between sexually transmitted pathogens and cervical intra-epithelial neoplasia in a developing community | Kharsany AB | 1993 | Durban | 48 | 11/28 (39%) | 3/20 (15%) | 6 |
5 | Trichomonas vaginalis and cervical cancer. A prospective study in China | Zhang ZF | 1995 | China | 16,797 | 7/421 (1.7%) | 92/16376 (0.6%) | 7 |
6 | Atypical squamous cells of undetermined significance: Bethesda classification and association with Human Papillomavirus | Barcelos AC | 2011 | Brazil | 170 | 4/140 (2.85%) | 0/30 (0) | 6 |
7 | Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer | Chen YC | 2013 | USA | 1382 | 71/690 (10%) | 61/692 (9%) | 6 |
8 | Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities Prevalence of human papillomavirus and co-existent sexually transmitted | Vieira P | 2016 | Portugal | 1244 | 31/905 (3.4%) | 11/339 (3.2%) | 6 |
9 | Prevalence of human papillomavirus, Chlamydia trachomatis, and Trichomonas vaginalis infections in Amazonian women with normal and abnormal cytology | Costa-Lira | 2017 | Brazil | 180 | 0/47 (0) | 24/133 (18%) | 6 |
10 | Correlation between Common Lower Genital Tract Microbes and High-Risk Human Papillomavirus Infection | Panpan Lv | 2019 | China | 826 | 8/254 (3.1%) | 1/572 (0.2%) | 6 |
11 | Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey | Ferré VM | 2019 | Togo | 310 | 9/102 (8.8%) | 11/208 (5.3%) | 6 |
12 | Association between Trichomonas vaginalis infection and cervical lesions: a population-based, nested case–control study in Taiwan | Su RY | 2020 | Taiwan | 270,015 | 12/54003 (0.02%) | 18/216012 (0.008%) | 6 |
13 | Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case–control study | Saleh NE | 2021 | Egypt | 445 | 57/325 (17.5%) | 10/120 (8.3%) | 6 |
14 | Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali | Jary A | 2021 | Mali | 144 | 7/90 (7.8%) | 3/54 (5.6%) | 7 |
15 | Infection with Trichomonas vaginalis in a black population | Miller JM | 1989 | USA | 3005 | 140/745 (18.8%) | 169/2260 (7.5%) | 6 |
16 | Gynaecological infections as risk determinants of subsequent cervical neoplasia | Viikki M | 2000 | Finland | 19,114 | 16/1544 (1.0%) | 82/17600 (0.5%) | 6 |
17 | Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents | Samoff E | 2005 | USA | 261 | 7/18 (39%) | 83/234 (35.8%) | 6 |
18 | Results of longterm hospital based cytological screening in asymptomatic women | Misra JS | 2006 | India | 20,417 | 54/671 (8.1%) | 485/19746 (2.5%) | 6 |
19 | Human Papillomaviruses and genital co-infections in gynaecological Outpatients | Verteramo R | 2008 | Italy | 857 | 3/10 (0.3%) | 263/847 (1.2%) | 7 |
20 | Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing | Tao L | 2014 | China | 748,105 | 9/5104 (1.8%) | 504/697064 (0.07%) | 6 |
21 | Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions | Ghosh I | 2017 | India | 225 | 130/177 (73.4%) | 27/48 (56.2%) | 6 |
22 | Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil | Belfort IKP | 2021 | Brazil | 562 | 21/107 (20%) | 27/455 (5.9%) | 7 |